LINEAGE CELL THERAPEUTICS IN's ticker is LCTX and the CUSIP is 53566P109. A total of 114 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q2 2024. The put-call ratio across all filers is 0.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $14,960 | -32.6% | 15,000 | 0.0% | 0.00% | -40.0% |
Q1 2024 | $22,200 | +35.8% | 15,000 | 0.0% | 0.01% | +25.0% |
Q4 2023 | $16,350 | -7.6% | 15,000 | 0.0% | 0.00% | -20.0% |
Q3 2023 | $17,700 | -16.3% | 15,000 | 0.0% | 0.01% | -16.7% |
Q2 2023 | $21,150 | -6.0% | 15,000 | 0.0% | 0.01% | -14.3% |
Q1 2023 | $22,500 | +28.2% | 15,000 | 0.0% | 0.01% | +16.7% |
Q4 2022 | $17,550 | +3.2% | 15,000 | 0.0% | 0.01% | 0.0% |
Q3 2022 | $17,000 | -29.2% | 15,000 | 0.0% | 0.01% | -25.0% |
Q2 2022 | $24,000 | +4.3% | 15,000 | 0.0% | 0.01% | +33.3% |
Q1 2022 | $23,000 | -37.8% | 15,000 | 0.0% | 0.01% | -33.3% |
Q4 2021 | $37,000 | -2.6% | 15,000 | 0.0% | 0.01% | -10.0% |
Q3 2021 | $38,000 | -11.6% | 15,000 | 0.0% | 0.01% | -16.7% |
Q2 2021 | $43,000 | +7.5% | 15,000 | 0.0% | 0.01% | +9.1% |
Q1 2021 | $40,000 | +53.8% | 15,000 | 0.0% | 0.01% | +37.5% |
Q4 2020 | $26,000 | +85.7% | 15,000 | 0.0% | 0.01% | +60.0% |
Q3 2020 | $14,000 | +7.7% | 15,000 | 0.0% | 0.01% | 0.0% |
Q2 2020 | $13,000 | +8.3% | 15,000 | 0.0% | 0.01% | -16.7% |
Q1 2020 | $12,000 | -7.7% | 15,000 | 0.0% | 0.01% | +50.0% |
Q4 2019 | $13,000 | – | 15,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BROADWOOD CAPITAL INC | 34,005,379 | $33,325,000 | 4.63% |
Defender Capital, LLC. | 3,794,045 | $3,709,000 | 3.29% |
Prescott General Partners LLC | 1,851,851 | $1,815,000 | 0.07% |
Northeast Financial Consultants Inc | 693,856 | $680,000 | 0.07% |
Beirne Wealth Consulting Services, LLC | 45,000 | $44,000 | 0.04% |
DAFNA Capital Management LLC | 95,000 | $93,000 | 0.04% |
Keudell/Morrison Wealth Management | 11,705 | $11,000 | 0.01% |
Regent Investment Management LLC | 20,000 | $20,000 | 0.01% |
Clarus Wealth Advisors | 10,147 | $10,000 | 0.01% |
Summit X, LLC | 18,200 | $18,000 | 0.01% |